Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases-Reference-Cited by-同舟云学术

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases

Published:2024-08 Issue:4 Volume:189 Page:
ISSN:0301-486X
Container-title:Mycopathologia
language:en
Short-container-title:Mycopathologia

Author:

Wang Jieru,Liu Li,Li Jia,Feng Xiaomeng,Yi Huiming,Jiang Erlie,Zheng Yizhou,Zhang Fengkui,Zhu Xiaofan,Mi Yingchang,Han Mingzhe,Wang Jianxiang,Feng Sizhou^ORCID

Funder

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and Peking Union Medical College

Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Haihe Laboratory of Cell Ecosystem Innovation Fund

Tianjin Municipal Science and Technology Commission Grant

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s11046-024-00875-w.pdf

Reference34 articles.

1. Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the transplant-associated infection surveillance network (TRANSNET) Database. Clin Infect Dis. 2010;50(8):1091–100. https://doi.org/10.1086/651263.

2. Jeong W, Keighley C, Wolfe R, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Clin Microbiol Infect. 2019;25(1):26–34. https://doi.org/10.1016/j.cmi.2018.07.011.

3. Puerta-Alcalde P, Garcia-Vidal C. Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation. J Fungi. 2021;7(10):848. https://doi.org/10.3390/jof7100848.

4. Choksi T, Agrawal A, Date P, et al. Cumulative mortality and factors associated with outcomes of mucormycosis after COVID-19 at a multispecialty tertiary care center in India. JAMA Ophthalmol. 2022;140(1):66–72. https://doi.org/10.1001/jamaophthalmol.2021.5201.

5. Katragkou A, Walsh TJ, Roilides E. Why is mucormycosis more difficult to cure than more common mycoses? Clin Microbiol Infect. 2014;20(6):74–81. https://doi.org/10.1111/1469-0691.12466.